Philip A. Kern, M.D., professor of internal medicine/endocrinology and co-director of the University of Kentucky Center for Clinical and Translational Science (CCTS), is co-principal investigator of an innovative new research project examining gene expression and regulatory activity in multiple metabolic cells—specifically, alterations to messenger RNA (mRNA)—that lead to the development of type 2 diabetes and obesity, with the goal of identifying potential targets for innovative treatments for the chronic conditions.
Rohit N. Kulkarni, M.D., Ph.D., the Diabetes Research and Wellness Foundation Endowed Chair and Co-Head of the Section on Islet & Regenerative Biology at the Joslin Diabetes Center at Beth Israel Lahey Health, is the lead principal investigator on the five-year, $9,920,607 award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). Additional co-principal investigators include Dr. Kern, as well as Chuan He, Ph.D., John T. Wilson Distinguished Service Professor, the University of Chicago; Mengjie Chen, Ph.D., Associate Professor of Medicine, Human Genetics and Statistics at the University of Chicago; and Ali Naji, M.D., Ph.D., Professor of Surgery, Associate Director of the Institute for Diabetes, Obesity and Metabolism at the University of Pennsylvania Perelman School of Medicine…
Read the full article here.
